Primary Category:
Treatment Protocols
Disease Category:
Colon, Gastrointestinal
Status:
Closed
Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
Eligible for screening study DCP 001
NCT#02912559
Site Delegation of Tasks Log required prior to registration of any patients.
A021502 is closed to accrual, effective January 17, 2023, at 4:30 PM ET.
